ArticleScientific reports2025
LGLoc as a new language model-driven graph neural network for mRNA localization.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The localization of mRNA is crucial for the synthesis of functional proteins and plays a significant role in cellular processes. Understanding mRNA localization can enhance applications in disease diagnosis (e.g., cancer, Alzheimer's) and drug development. While numerous methods have been developed for this purpose, existing approaches face challenges: experimental methods are often costly and time-consuming, while computational methods may lack accuracy and efficiency. To address these limitations, we propose LGLoc, a machine learning-based approach designed to improve the accuracy of mRNA localization predictions with low computational overhead. LGLoc employs a Graph Neural Network encoder that utilizes the RNA's secondary structure, complemented by a BERT encoder focused on the primary RNA sequence. Additionally, it integrates k-mer and nucleotide frequency-based encoders to capture essential sequence characteristics. Feature selection is conducted using an analysis of variance, and classification is performed through a one-vs-rest Naïve Bayes classifier tailored for mRNA classification. Our results indicate that LGLoc significantly outperforms existing methods, such as mRNALoc and MSLP, across key performance metrics including Accuracy, Sensitivity, Specificity, F1-score, AUC, and MCC. Notably, LGLoc achieves over 49% improvement in average F1-score and 26% in average MCC compared to mRNALoc, demonstrating its reliability and effectiveness in mRNA subcellular localization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.